Free Trial

Select Medical Holdings Co. (NYSE:SEM) Shares Acquired by Vanguard Group Inc.

Select Medical logo with Medical background
Remove Ads

Vanguard Group Inc. grew its position in Select Medical Holdings Co. (NYSE:SEM - Free Report) by 1.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 12,712,990 shares of the health services provider's stock after acquiring an additional 131,228 shares during the quarter. Vanguard Group Inc. owned about 9.82% of Select Medical worth $239,640,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the company. JPMorgan Chase & Co. lifted its holdings in Select Medical by 9.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 416,299 shares of the health services provider's stock valued at $14,516,000 after purchasing an additional 36,905 shares in the last quarter. Argent Capital Management LLC raised its position in shares of Select Medical by 79.8% in the fourth quarter. Argent Capital Management LLC now owns 55,144 shares of the health services provider's stock valued at $1,039,000 after buying an additional 24,471 shares during the last quarter. Geode Capital Management LLC boosted its position in Select Medical by 2.0% during the third quarter. Geode Capital Management LLC now owns 2,442,321 shares of the health services provider's stock worth $85,180,000 after acquiring an additional 46,880 shares during the last quarter. American Century Companies Inc. grew its stake in Select Medical by 1,309.5% during the 4th quarter. American Century Companies Inc. now owns 137,169 shares of the health services provider's stock valued at $2,586,000 after acquiring an additional 127,437 shares in the last quarter. Finally, Sanctuary Advisors LLC raised its holdings in Select Medical by 122.8% in the 4th quarter. Sanctuary Advisors LLC now owns 52,175 shares of the health services provider's stock valued at $1,035,000 after acquiring an additional 28,759 shares during the last quarter. 89.48% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Analysts Set New Price Targets

A number of research firms have recently issued reports on SEM. StockNews.com upgraded Select Medical from a "hold" rating to a "buy" rating in a research report on Friday, February 21st. Royal Bank of Canada dropped their target price on Select Medical from $47.00 to $23.00 and set an "outperform" rating for the company in a report on Monday, February 24th. Benchmark upgraded Select Medical from a "hold" rating to a "buy" rating and set a $23.00 price target on the stock in a report on Monday, February 24th. Finally, UBS Group dropped their price objective on shares of Select Medical from $40.00 to $21.00 and set a "neutral" rating for the company in a report on Friday, January 3rd. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $27.25.

Get Our Latest Analysis on Select Medical

Select Medical Trading Down 3.7 %

NYSE SEM traded down $0.63 during trading hours on Thursday, reaching $16.36. The company had a trading volume of 826,661 shares, compared to its average volume of 809,713. Select Medical Holdings Co. has a 1-year low of $14.99 and a 1-year high of $40.98. The stock has a market capitalization of $2.11 billion, a P/E ratio of 9.91, a price-to-earnings-growth ratio of 0.64 and a beta of 1.38. The stock has a 50-day moving average of $17.63 and a 200 day moving average of $23.66. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.37.

Select Medical (NYSE:SEM - Get Free Report) last released its quarterly earnings results on Thursday, February 20th. The health services provider reported $0.18 EPS for the quarter, missing the consensus estimate of $0.29 by ($0.11). The firm had revenue of $1.31 billion for the quarter, compared to analysts' expectations of $1.50 billion. Select Medical had a return on equity of 14.04% and a net margin of 3.23%. As a group, research analysts anticipate that Select Medical Holdings Co. will post 1.17 earnings per share for the current fiscal year.

Select Medical Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, March 13th. Shareholders of record on Monday, March 3rd were issued a dividend of $0.0625 per share. The ex-dividend date was Monday, March 3rd. This represents a $0.25 dividend on an annualized basis and a yield of 1.53%. Select Medical's dividend payout ratio (DPR) is presently 15.15%.

Select Medical Company Profile

(Free Report)

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

Featured Articles

Institutional Ownership by Quarter for Select Medical (NYSE:SEM)

Should You Invest $1,000 in Select Medical Right Now?

Before you consider Select Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.

While Select Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Congress Bought THESE Stocks as Tariffs Tanked the Market

Congress Bought THESE Stocks as Tariffs Tanked the Market

Reports of congressional buying and selling during the tariff meltdown are coming in; find out which companies members of Congress bought and sold.

Related Videos

5 Stocks to BUY Now as Tariff Uncertainty Fades
Donald Trump Owns These 7 Stocks, Should You?
Donald Trump Owns These 7 Stocks, Should You?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads